News

Johnson & Johnson hit with $247 million verdict in hip implant trial

Article published by Reuters.  Delivering a third straight win to patients, the jury found that the metal-on-metal hip implants were defectively designed and that the companies failed to warn consumers about the risks.  Read more  here.

Last modified: Tue, 27 Feb 2018 12:16:14 GMT